IRIS UniCatt

Bianchi, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.094
EU - Europa 3.752
AS - Asia 3.491
SA - Sud America 973
AF - Africa 104
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 12.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.927
SG - Singapore 1.693
DE - Germania 1.106
CN - Cina 880
BR - Brasile 801
IT - Italia 573
SE - Svezia 521
VN - Vietnam 263
UA - Ucraina 249
PL - Polonia 242
FR - Francia 219
GB - Regno Unito 186
IE - Irlanda 159
FI - Finlandia 148
RU - Federazione Russa 136
IN - India 127
ID - Indonesia 124
CA - Canada 83
AR - Argentina 68
MX - Messico 55
HK - Hong Kong 53
BD - Bangladesh 44
JP - Giappone 42
NL - Olanda 42
AT - Austria 40
TR - Turchia 40
IQ - Iraq 38
ZA - Sudafrica 30
BE - Belgio 29
ES - Italia 26
KR - Corea 25
VE - Venezuela 23
EC - Ecuador 22
IR - Iran 21
AE - Emirati Arabi Uniti 17
EG - Egitto 16
CO - Colombia 15
PK - Pakistan 15
UZ - Uzbekistan 14
MA - Marocco 13
PY - Paraguay 13
SA - Arabia Saudita 13
CL - Cile 12
CI - Costa d'Avorio 11
KZ - Kazakistan 11
CH - Svizzera 10
CZ - Repubblica Ceca 10
KE - Kenya 10
PE - Perù 10
AL - Albania 9
PT - Portogallo 9
JO - Giordania 8
RO - Romania 8
LB - Libano 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
IL - Israele 6
LK - Sri Lanka 6
LT - Lituania 6
UY - Uruguay 6
BH - Bahrain 5
JM - Giamaica 5
NP - Nepal 5
ET - Etiopia 4
GE - Georgia 4
HN - Honduras 4
MD - Moldavia 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
KG - Kirghizistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PH - Filippine 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BS - Bahamas 2
DZ - Algeria 2
GA - Gabon 2
GR - Grecia 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
VA - Santa Sede (Città del Vaticano) 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
Totale 12.409
Salva come PNG Salva come JPEG
Città #
Singapore 813
Chandler 613
Ashburn 400
Warsaw 218
Beijing 190
New York 182
Dublin 147
Los Angeles 141
Rome 138
San Mateo 126
Hefei 118
Ann Arbor 114
Jakarta 105
Ho Chi Minh City 99
Jacksonville 96
Fairfield 93
São Paulo 93
Wilmington 93
Moscow 86
Munich 81
Milan 75
Boston 74
Dallas 72
Nanjing 68
The Dalles 67
Seattle 62
Hanoi 61
Marseille 60
Houston 59
Helsinki 56
Frankfurt am Main 55
Hong Kong 51
Chicago 50
Woodbridge 50
Princeton 49
Bremen 48
Kent 46
Nürnberg 46
Cattolica 41
Montreal 41
Turku 38
Dearborn 35
Nuremberg 32
Zhengzhou 32
London 31
Santa Clara 31
Denver 30
Boardman 29
Brooklyn 29
Rio de Janeiro 29
Redwood City 28
Brussels 27
Cambridge 27
Lawrence 27
Tokyo 27
Hyderabad 26
Orem 26
Nanchang 25
Seoul 24
Mountain View 23
Buffalo 22
North Bergen 22
Stockholm 22
Belo Horizonte 21
University Park 21
Bexley 20
Norwalk 19
Phoenix 18
Hangzhou 17
Vienna 17
Atlanta 16
Düsseldorf 16
Shenyang 16
Trieste 16
Augusta 15
Baghdad 15
Lappeenranta 15
Mexico City 15
Johannesburg 14
Poplar 14
Amsterdam 13
Hebei 13
Kraków 13
Lauterbourg 13
Redmond 13
Shanghai 13
Tashkent 13
Tianjin 13
Chennai 12
Guangzhou 12
Kunming 12
Leawood 12
Mumbai 12
Querétaro 12
Abidjan 11
Dhaka 11
Fremont 11
Izmir 11
Porto Alegre 11
Toronto 11
Totale 6.246
Salva come PNG Salva come JPEG
Nome #
Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis. 391
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 277
Hypophysitis Outcome and Factors Predicting Responsiveness to Glucocorticoid Therapy: A Prospective and Double-Arm Study. 277
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 254
Double pituitary adenomas 225
Predictors of morbidity and mortality in acromegaly, an Italian survey. 212
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 189
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 186
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 186
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 179
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 175
Assessment of neurological manifestations in hospitalized patients with COVID-19 172
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 164
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 153
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 143
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 138
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 138
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 137
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 135
The Changing Clinical Spectrum of Hypophysitis 135
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 134
Hypothalamitis: a diagnostic and therapeutic challenge 132
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 130
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 128
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 127
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study 126
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 122
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 122
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 121
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 120
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 119
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 114
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 114
GH receptor isoforms and skeletal fragility in acromegaly 110
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 108
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 107
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 107
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 106
Spontaneous thyroid nodule hemorrhage in the emergency department 104
Effects of thyroid hormone treatment on diaphragmatic efficiency in mechanically ventilated subjects with nonthyroidal illness syndrome 103
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 103
Empty sella syndrome: Multiple endocrine disorders. 102
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 100
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 100
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 99
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 98
Autoantibody reactivity profile of primary autoimmune hypophysitis patients: preliminary results 98
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 97
Pediatric craniopharyngiomas: magnetic resonance imaging assessment for hypothalamus-pituitary axis dysfunction and outcome prediction 96
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 95
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 94
Vertebral fractures in patients with acromegaly: a 3-year prospective study 93
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 93
Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis 92
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 91
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 90
High prevalence of hyperplastic colonic polyps in acromegalic subjects 90
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs. 90
Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant 89
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype? 89
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 88
Vertebral fractures in males with prolactinoma. 87
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 87
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 87
Hypothalamitis and pituitary atrophy 87
Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy 86
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 86
Understanding the effect of acromegaly on the human skeleton. 86
Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review 85
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly. 83
Neuropsychiatric symptoms, oral pigmentation and fever as revealing hints of autoimmune Addison’s disease 82
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 82
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 82
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 80
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 79
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition 78
Diabetic neuropathy: a risk factor for severe COVID-19? 77
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 77
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study 77
The Differential Diagnosis between Pseudo Cushing's Syndrome and True Cushing's Syndrome in a Septic Patient in the Pre-Agonal Phase: A Case Report 76
Systemic mastocytosis mimicking carcinoid syndrome 76
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors 73
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly 73
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. 73
Genes of the “regulation of lymphocyte activation” pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors 72
Prevalence of morphometric vertebral fractures in "difficult" patients with acromegaly with different biochemical outcomes after multimodal treatment. 72
Tumor features in adult papillary and adamantinomatous craniopharyngioma: neuroradiological evaluation of pituitary-hypothalamic-axis dysfunction and outcome prediction 71
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 71
Acromegaly can be cured by first-line pasireotide treatment? 70
Systemic comorbidities of acromegaly in real-life experience: which difference among young and elderly patients? 69
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries 68
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 68
Acromegaly in the elderly patients 67
Letter: A Multicenter, Propensity Score- Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 66
CD68+ and CD8+ immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs 65
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU 65
LCM-RNAseq Highlights Intratumor Heterogeneity and a lncRNA Signature from Archival Tissues of GH-Secreting PitNETs 64
The multi-biomarker acro-TIME score predicts fg-SRLs response: preliminary results of a retrospective acromegaly cohort 64
Empty sella syndrome: an update 64
Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach 64
Totale 11.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 32 76 13 57 47 93 11
2021/2022774 29 44 10 73 87 34 21 130 26 49 110 161
2022/20231.720 193 228 140 272 101 236 98 142 182 24 65 39
2023/2024919 38 209 33 46 44 150 47 20 33 55 104 140
2024/20252.383 45 52 161 95 139 89 61 94 345 241 494 567
2025/20264.148 919 286 528 1.010 1.118 287 0 0 0 0 0 0
Totale 12.677